Achieve Life Sciences, Inc.
ACHV- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000949858
In the last 90 days, Achieve Life Sciences, Inc. insiders filed 0 open-market purchases and 1 sale; 111 institutions reported holding it in 13F filings for Q2 2026, worth $538.7M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Achieve Life Sciences, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 56 | 2 | 64 | +10 |
| Shares | 18.6M | 2.03M | 16.9M | +381.7K (+2.3%) |
| Value | $78.4M | $9.53M | $81.2M | +$12.3M (+17.9%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Achieve Life Sciences, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 2,071,132 | $9.82M | 0.00% |
| Pale Fire Capital SE | 33,119 | $157.0K | 0.02% |
| Verition Fund Management LLC | 23,805 | $112.8K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 18,897 | $89.6K | 0.00% |
| Jane Street Group, LLC | 14,891 | $70.6K | 0.00% |
| SG Americas Securities, LLC | 11,374 | $54.0K | 0.00% |
| Windsor Capital Management, LLC | 10,817 | $51.3K | 0.01% |
| FMR LLC | 2,057 | $9.75K | 0.00% |
| Russell Investments Group, Ltd. | 2,057 | $9.75K | 0.00% |
| CWM, LLC | 212 | $1.00K | 0.00% |
| Capital Performance Advisors LLP | 77 | $365 | 0.00% |
| Sterling Capital Management LLC | 64 | $303 | 0.00% |
| Citadel Advisors LLC | 6 | $28 | 0.00% |
Sold out (3)
Institutions that held Achieve Life Sciences, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Altium Capital Management LP | 216,310 | $1.02M |
| Millennium Management LLC | 18,295 | $86.0K |
| STRS Ohio | 6,400 | $30.1K |
Not filed for Q3 2024 yet (2)
Institutions that held Achieve Life Sciences, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,956,510 | $9.20M |
| CVI Holdings, LLC | 71,749 | $337.2K |